Therefore, inhibiting the release of IL1β, IL6, and TNFα can effectively reduce neuron apoptosis, improve neurological deficits, reduce the disability rate and improve the quality of life of patients with cerebral ischemia. The gene discussed is IL1B; the disease is brain ischemia.